Barbara Skerritt, ICON plc - Qepler Summits And Conferences

Barbara Skerritt

Director, Product Innovation, Information Technology
ICON plc
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries.

With over 25 years clinical trial experience, Barbara Skerritt is a Director Product Innovation and is part of the multidisciplinary Innovation Team at ICON.

Barbara is currently leading Prof. Michael Porter’s, of the Harvard Business School founded initiative, International Consortium for Health Outcome Measurement (ICHOM) GLobal Outcomes Benchmarking (GLOBE) Pilot Program.

As ICHOM’s data partner, ICON is collecting clinical and patient reported outcome data directly from Hospitals globally. Barbara is also involved in the assessing the feasibility and usability of technologies such as Bring Your Own Device (BYOD) and actigraphy sensors in the clinical trial setting.

Barbara has presented at conferences and has published in peer-reviewed journals related to her area of expertise, using digital technology in clinical trials.

Related Sessions:

Pharmaceutical R&D
Informatics Summit 2019

Improving R&D process with computational transformation: AI & ML, Advanced Data Sciences & New Methods.
  • 26 Sep 2019
  • Vienna, AT
  • Pharma
Day 1: Thursday, 26 September 2019
CASE STUDY: ICHOM and ICON - GLobal Outcomes BEnchmarking (GLOBE) Pilot Program.
View Details